|
Volumn 2, Issue 1, 2013, Pages
|
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
MORPHOLINE DERIVATIVE;
RIVAROXABAN;
THIOPHENE DERIVATIVE;
WARFARIN;
AGED;
ARTICLE;
ASIA;
BLOOD;
BLOOD CLOTTING;
CEREBROVASCULAR ACCIDENT;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG MONITORING;
EUROPE;
FEMALE;
HEALTH CARE DISPARITY;
HEART ATRIUM FIBRILLATION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
MALE;
METHODOLOGY;
MULTICENTER STUDY;
MULTIVARIATE ANALYSIS;
NORTH AMERICA;
PREDICTIVE VALUE;
RANDOMIZED CONTROLLED TRIAL;
SOUTH AFRICA;
SOUTH AMERICA;
STATISTICAL MODEL;
TIME;
TREATMENT OUTCOME;
AGED;
ANTICOAGULANTS;
ASIA;
ATRIAL FIBRILLATION;
BLOOD COAGULATION;
DOUBLE-BLIND METHOD;
DRUG MONITORING;
EUROPE;
FEMALE;
HEALTHCARE DISPARITIES;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
LINEAR MODELS;
MALE;
MORPHOLINES;
MULTIVARIATE ANALYSIS;
NORTH AMERICA;
PREDICTIVE VALUE OF TESTS;
RESIDENCE CHARACTERISTICS;
SOUTH AFRICA;
SOUTH AMERICA;
STROKE;
THIOPHENES;
TIME FACTORS;
TREATMENT OUTCOME;
WARFARIN;
|
EID: 84878659651
PISSN: None
EISSN: 20479980
Source Type: None
DOI: 10.1161/JAHA.112.000067 Document Type: Article |
Times cited : (190)
|
References (0)
|